Axithra
Latest round
- Seed
Last raised
- Aug 2023
Total raised
- $11M
Investors
- 9
About Axithra
V. is a spin-off of Imec and Ghent University that operates as a developer of therapeutic drug monitoring devices.xpand and Kurma Partners, including Qbic, Noshaq, White Fund, Wallonie Entreprendre, Hamamatsu Photonics, and Werfen Diagnostics. As of 2023, Leander Van Nest serves as the CEO of the company. The company provides a therapeutic drug monitoring (TDM) device that measures drug concentrations in patient’s blood. The firm’s platform is customizable for medication for each unique patient, even under changing conditions and in a variety of settings, including outside of the hospital lab.
Who invested in Axithra
9 investors across 1 round
See all investors in Axithra
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 1, 2023
Amount
$11M
Investors
Questions about Axithra
Who invested in Axithra?
Axithra has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Axithra raised?
Axithra has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Axithra last raise money?
Axithra's most recent round on record is a Seed, in Aug 2023.
What does Axithra do?
Axithra is a medical devices & equipment company.
Where is Axithra headquartered?
Axithra is headquartered in Gent, Belgium.
Which VCs invest in companies like Axithra?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Axithra's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Axithra? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.